亨廷顿病的认知缺陷在神经心理状态评估的可重复电池上。
Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
机构信息
Department of Psychiatry, University of Iowa, Iowa City, IA 52242-1000, USA.
出版信息
J Clin Exp Neuropsychol. 2010 Mar;32(3):231-8. doi: 10.1080/13803390902926184. Epub 2009 May 29.
Abstract
Huntington's disease (HD) is associated with a variety of cognitive deficits, as well as motor and psychiatric disturbances. As clinical trials for HD evolve, briefer screening instruments will be needed to determine cognitive effects of interventions. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) may fill this gap. A total of 75 participants diagnosed with HD were evaluated with the RBANS, as well as several other scales typically used in HD. RBANS performances for these participants fell significantly below expectations for the Total Scale score, all five Indexes, and 11 of the 12 individual subtests. Cognitive scores on the RBANS were also significantly related to other markers of HD, including motor abnormalities, functional abilities, and other cognitive scores. Although additional research is needed, the current study supports the clinical applicability of the RBANS in patients with HD.
摘要
亨廷顿病（HD）与多种认知缺陷、运动和精神障碍有关。随着 HD 临床试验的发展，需要更简短的筛选工具来确定干预措施对认知的影响。重复性成套神经心理状态测验（RBANS）可能会填补这一空白。共有 75 名被诊断为 HD 的参与者接受了 RBANS 以及其他几种通常用于 HD 的量表的评估。这些参与者的 RBANS 表现明显低于总评分、五个指数和 12 个单项测试中的 11 个的预期。RBANS 的认知评分也与 HD 的其他标志物显著相关，包括运动异常、功能能力和其他认知评分。虽然还需要进一步的研究，但目前的研究支持 RBANS 在 HD 患者中的临床适用性。
相似文献
1
Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
J Clin Exp Neuropsychol. 2010 Mar;32(3):231-8. doi: 10.1080/13803390902926184. Epub 2009 May 29.
2
Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
J Clin Exp Neuropsychol. 2019 Jul;41(5):469-475. doi: 10.1080/13803395.2019.1572073. Epub 2019 Feb 4.
3
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.
J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9. doi: 10.1076/jcen.20.3.310.823.
4
Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
J Clin Exp Neuropsychol. 2010 Jul;32(6):573-8. doi: 10.1080/13803390903313564. Epub 2009 Oct 29.
5
The Repeatable Battery for the Assessment of Neuropsychological Status, While Useful for Measuring Cognitive Changes in Manifest Huntington Disease, May Show Limited Utility in Premanifest Disease.
Cogn Behav Neurol. 2022 Sep 1;35(3):198-203. doi: 10.1097/WNN.0000000000000310.
6
Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
Neuropsychology. 2015 Mar;29(2):268-73. doi: 10.1037/neu0000134. Epub 2014 Aug 11.
7
Factor Structure of the Repeatable Battery for the Assessment of Neuropsychological Status in Huntington's Disease.
Arch Clin Neuropsychol. 2022 Feb 23;37(2):473-478. doi: 10.1093/arclin/acab050.
8
Evidence for specific cognitive deficits in preclinical Huntington's disease.
Brain. 1998 Jul;121 ( Pt 7):1329-41. doi: 10.1093/brain/121.7.1329.
9
The repeatable battery for the assessment of neuropsychological status (RBANS): clinical utility in a traumatic brain injury sample.
Clin Neuropsychol. 2008 Mar;22(2):228-41. doi: 10.1080/13854040701260370.
10
Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
Am J Psychiatry. 1999 Dec;156(12):1951-7. doi: 10.1176/ajp.156.12.1951.
引用本文的文献
1
Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington's disease.
Sci Rep. 2025 Feb 8;15(1):4707. doi: 10.1038/s41598-025-88406-5.
2
Recognition subtests of the Repeatable Battery for the Assessment of Neuropsychological Status: evidence for a cortical vs. subcortical distinction.
J Clin Exp Neuropsychol. 2023 Oct;45(8):786-797. doi: 10.1080/13803395.2023.2259044. Epub 2023 Sep 20.
3
LASSI-L detects early cognitive changes in pre-motor manifest Huntington's disease: a replication and validation study.
Front Neurol. 2023 Jul 18;14:1191718. doi: 10.3389/fneur.2023.1191718. eCollection 2023.
4
Recall and recognition subtests of the repeatable battery for the assessment of neuropsychological status and their relationship to biomarkers of Alzheimer's disease.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2023 Sep-Nov;30(6):885-902. doi: 10.1080/13825585.2022.2124229. Epub 2022 Sep 15.
5
The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis.
Neuropsychol Rev. 2023 Jun;33(2):514-543. doi: 10.1007/s11065-022-09551-6. Epub 2022 Aug 12.
6
Recognition subtests for the Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary data in cognitively intact older adults, amnestic Mild Cognitive Impairment, and Alzheimer's disease.
Clin Neuropsychol. 2021 Nov;35(8):1415-1425. doi: 10.1080/13854046.2020.1812724. Epub 2020 Sep 3.
7
Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden.
Arch Clin Neuropsychol. 2021 Jan 15;36(1):74-86. doi: 10.1093/arclin/acaa038.
8
Sleep Disorders in Huntington's Disease.
Front Psychiatry. 2019 Apr 12;10:221. doi: 10.3389/fpsyt.2019.00221. eCollection 2019.
9
Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
J Clin Exp Neuropsychol. 2019 Jul;41(5):469-475. doi: 10.1080/13803395.2019.1572073. Epub 2019 Feb 4.
10
RBANS Validity Indices: a Systematic Review and Meta-Analysis.
Neuropsychol Rev. 2018 Sep;28(3):269-284. doi: 10.1007/s11065-018-9377-5. Epub 2018 May 16.
本文引用的文献
1
Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers.
Arch Clin Neuropsychol. 2008 Sep;23(5):603-12. doi: 10.1016/j.acn.2008.06.004. Epub 2008 Jul 17.
2
Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
Brain. 2008 Apr;131(Pt 4):1057-68. doi: 10.1093/brain/awn025. Epub 2008 Mar 12.
3
Frontal-subcortical dementias.
Neurologist. 2008 Mar;14(2):100-7. doi: 10.1097/NRL.0b013e31815b0de2.
4
Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80. doi: 10.1136/jnnp.2007.128728. Epub 2007 Dec 20.
5
Morphology of the cerebral cortex in preclinical Huntington's disease.
Am J Psychiatry. 2007 Sep;164(9):1428-34. doi: 10.1176/appi.ajp.2007.06081266.
6
Modified scoring criteria for the RBANS figures.
Appl Neuropsychol. 2007;14(2):73-83. doi: 10.1080/09084280701319805.
7
Neuropsychology of cortical versus subcortical dementia syndromes.
Semin Neurol. 2007 Feb;27(1):7-21. doi: 10.1055/s-2006-956751.
8
Probability of obsessive and compulsive symptoms in Huntington's disease.
Biol Psychiatry. 2007 Feb 1;61(3):415-8. doi: 10.1016/j.biopsych.2006.04.034. Epub 2006 Jul 12.
9
Episodic memory impairment in Huntington's disease: a meta-analysis.
Neuropsychologia. 2006;44(10):1984-94. doi: 10.1016/j.neuropsychologia.2006.01.015. Epub 2006 Jun 23.
10
Preparing for preventive clinical trials: the Predict-HD study.
Arch Neurol. 2006 Jun;63(6):883-90. doi: 10.1001/archneur.63.6.883.
Zotero 插件